Inventor

BOITEAU JEAN-GUY

FR36 patents

⚠️ This page may combine multiple inventors who share the name “BOITEAU JEAN-GUY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BOITEAU JEAN-GUY

GALDERMA RES & DEV

Angiogenesis inhibitors and pharmaceutical and cosmetic use thereof

Method of synthesising 4-piperidin-4-yl-benzene-1,3-diol and the salts of same and novel compound tert-butyl 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylate

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies

Biaromatic compound activators of PPARγ receptors and cosmetic/pharmaceutical compositions comprised thereof

Method of crosslinking glycosaminoglycans

Method of crosslinking glycosaminoglycans

Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compounds

4-(heterocycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics

Method for the synthesis of (Z)-3-[2-butoxy-3′-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl]-2-methoxy-acrylic acid

Methods for activating PPAR gamma-type receptors

Biaromatic compounds which activate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprised thereof

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases

3-phenylpropanoic compound activators of receptors of PPAR type and pharmaceutical/cosmetic compositions comprised thereof

4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics

Selective compounds inhibiting CYP26A1 useful in cosmetic and pharmaceutical compositions

Biaromatic compounds that modulate PPAR-receptors

Method for synthesizing enantiomerically pure N-(pyridin-4-yl)-2-hydroxy-alkylamide derivatives

4-heteroarylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof

BOITEAU JEAN-GUY

Biaromatic compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof

4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics

4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics

3-phenyl acrylic acid compound activators of type PPAR receptors and pharmaceutical/cosmetic compositions comprised thereof

Metronidazole esters for treating rosacea

Metronidazole esters for treating rosacea

Biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof

4-phenylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof

GALDERMA SA

Carbohydrate crosslinker

Grafting of cyclodextrin by amide bonds to an ether cross-linked hyaluronic acid and uses thereof

Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereof

Single step functionalization and cross-linking of hyaluronic acid

Enantiopure or enantioenriched BDDE and its use as crosslinking agent in the manufacture of cross-linked products

Galderma Holding SA

Carbohydrate crosslinker

Carbohydrate crosslinker